The decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised. Read Article […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-14 08:23:242021-08-16 08:25:46F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systems
Dan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/harvard-gazette.jpg275281Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-09 14:38:152021-08-09 14:38:15Dan Barouch and the birth of the J&J COVID vaccine
“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:32:512021-08-09 09:33:58New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/10/wsj.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:30:142021-08-09 09:31:11J&J Vaccine Highly Effective Against Delta Variant in South African Trial
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/AA0O_yzc_400x400.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-21 09:27:142021-07-22 09:38:03We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
Dan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/ABCNEWS.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-08 13:33:492021-07-09 13:35:32Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
The Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/NPR.png16381638Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-02 08:34:262021-07-02 08:34:26Johnson & Johnson Vaccine Protects Against Delta Variant Of COVID, Study Finds
The Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in […]
Johnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in […]
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systems
/in NewsThe decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised. Read Article […]
Dan Barouch and the birth of the J&J COVID vaccine
/in NewsDan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
/in News“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
J&J Vaccine Highly Effective Against Delta Variant in South African Trial
/in NewsStudy finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
/in News“The more breakthroughs you have, the easier it is to determine,” Katy Stephenson. Read Article
Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
/in NewsDan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
Johnson & Johnson Vaccine Protects Against Delta Variant Of COVID, Study Finds
/in NewsThe Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find
/in NewsThe Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in […]
J&J coronavirus vaccine appears to protect against Delta variant
/in NewsJohnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in […]
J&J Covid Shot Neutralizes Delta Variant, Company Says
/in NewsJohnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article